Patents-Review.com
ClassID:

111419 ⎘

C12N2770/28122 - CPC Classification

Classification description:

ssRNA viruses positive-sense; Details; Hepeviridae; Hepevirus, e.g. hepatitis E virus New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Recent Application in this class:
#1
20250136643
2025-05-01

HEPATITIS C VIRUS E1/E2 HETERODIMERS AND METHODS OF PRODUCING SAME

 #2
20230340030
2023-10-26

HEPATITIS E VIRUS ORF2 CAPSID POLYPEPTIDES AND USES THEREOF

 #3
20230159596
2023-05-25

Virus-like nanoparticles for oral delivery

 #4
20220041661
2022-02-10

Hepatitis c virus E1/E2 heterodimers and methods of producing same

 #5
20210221850
2021-07-22

Virus-like nanoparticles for oral delivery

 #6
20210179669
2021-06-17

HEPATITIS E VIRUS ORF2 CAPSID POLYPEPTIDES AND USES THEREOF

 #7
20210038697
2021-02-11

VIRUS-LIKE NANOCAPSID FOR ORAL DELIVERY OF INSULIN

 #8
20190352342
2019-11-21

Hepatitis E virus ORF2 capsid polypeptides and uses thereof

 #9
20190031720
2019-01-31

CHEMICALLY ACTIVATED NANOCAPSID FUNCTIONALIZED FOR CANCER TARGETING

 #10
20180328929
2018-11-15

Mutated HEV polypeptides and the use thereof for assaying anti-HEV antibodies

 #11
20180282377
2018-10-04

Hepatitis C virus E1/E2 heterodimers and methods of producing same

 #12
20170107261
2017-04-20

Chemically activated nanocapsid functionalized for cancer targeting

 #13
20170015713
2017-01-19

Fusion protein comprising diphtheria toxin non-toxic mutant CRM197 or fragment thereof

 #14
20170014506
2017-01-19

Fusion protein comprising diphtheria toxin non-toxic mutant CRM197 or fragment thereof

 #15
20160102296
2016-04-14

Infectious hepatitis E virus genotype 3 recombinants

 #16
20140134199
2014-05-15

Fusion protein comprising diphtheria toxin non-toxic mutant CRM197 or fragment thereof

 #17
20140017269
2014-01-16

Protein complex system for increased immunogenicity and functionality, and methods making and use

 #18
20130302790
2013-11-14

Infectious hepatitis E virus genotype 3 recombinants

 #19
20100173283
2010-07-08

METHOD OF PREDICTING POTENTIAL SEVERITY OF HEPATITIS E, PROBE SETS, AND PRIMER SETS

 #20
20100150962
2010-06-17

Polypeptide fragments of the hepatitis E virus, the vaccine composition comprising said fragments and the diagnostic kits

 #21
20100143410
2010-06-10

Polypeptide fragments of the hepatitis E virus, the vaccine composition comprising said fragments and the diagnostic kits

 #22
20100003281
2010-01-07

Monoclonal antibody against hepatitis E virus or its fragment with binding activity and use thereof

 #23
20060233822
2006-10-19

Monoclonal antibody against hepatitis E virus or its fragment with binding activity and use thereof

 #24
20050233316
2005-10-20

Major neutralization site of hepatitis E virus and use of this neutralization site in methods of vaccination and in methods of screening for neutralizing antibodies to hepatitis E virus